Today i asked Jon if he could advise in relation to the Phelan-McDermid trial how many patients have completed the trial, how many are currently completing the trial and how many participants are required in each of the three age groups. Jon advised that none of that is public information and therefore he couldnt disclose however he did advise they "currently have patients in all three groups". I followed up with whether that meant the youngest group has commenced the trial- his reply "Yes, correct".
Thats great progress. I was expecting a read out in November but could be a couple months earlier.
Share Price, page-4807
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B | |||
| Open | High | Low | Value | Volume |
| $16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 830 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.74 | 1484 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |